Dr. Haji Bahadar

Biography

Dr. Haji Bahadar is an Associate Professor with a Pharm-D from the University of Peshawar and a PhD in Pharmacology and Toxicology from Tehran University of Medical Sciences, Iran. He has extensive academic and research experience in environmental and occupational toxicology, with a particular focus on the effects of benzene, mercury, pesticides, and nanoparticles on human health.

His research encompasses metabolic toxicology, immunotoxicology, oxidative stress, drug discovery, and genetic epidemiology, including investigations into environmental toxicants associated with diabetes and metabolic disorders. He served as a Research Assistant at Tehran University of Medical Sciences, Tehran, Iran, and subsequently joined the Institute of Pharmaceutical Sciences (IPS), Khyber Medical University (KMU), where he served as an Assistant Professor from August 2016 to 2025 and currently serves as an Associate Professor since 2025.

In addition to his academic role, Dr. Bahadar has held several important administrative and academic responsibilities at IPS, KMU. He served as Chief Proctor (2020–2026) and Pharm-D Academic Coordinator (2021–2026). He has also been serving as Chairman, Anti-Tobacco and Drugs, IPS, KMU, since 2021.

Dr. Bahadar has contributed extensively to international scientific literature and is a contributor to Elsevier’s Encyclopedia of Toxicology, with four book chapters to his credit. He is actively involved in postgraduate research supervision and serves as a peer reviewer for several international scientific journals.

Research Interests

Endocrinology & Toxicology

Publications

• The molecular mechanisms of liver and islets of Langerhans toxicity by benzene and its metabolite hydroquinone in vivo and in vitro (vol 25, pg 628, 2015) — Haji Bahadar, Faheem Maqbool, Sara Mostafalou, Maryam Baeeri, Mahdi Gholami, Elmira Ghafour-Boroujerdi, Mohammad Abdollahi , Journal (2025)
• Corrigendum to “α-Lipoic acid prevents senescence, cell cycle arrest, and inflammatory cues in fibroblasts by inhibiting oxidative stress”[Pharmacol. Res. 141 (2019) 214–223] — Maryam Baeeri, Haji Bahadar, Mahban Rahimifard, Mona Navaei-Nigjeh, Reza Khorasani, Mohammad Amin Rezvanfar, Mahdi Gholami, Mohammad Abdollahi , Journal (2024)
• Modulation of oxidative stress/NMDA/nitric oxide pathway by topiramate attenuates morphine dependence in mice — Shabir Hussain, Haji Bahadar, Muhammad Imran Khan, Neelum Gul Qazi, Shabnum Gul Wazir, Habab Ali Ahmad , Journal (2024)
• Muscle relaxant and antipyretic effects of pentacyclic triterpenes isolated from the roots of Diospyros lotus L — Ajmal Khan, Hamdy Kashtoh, Abdur Rauf, Sobia Ahsan Halim, Awan A Aleem, Haji Bahadar, Huma Shareef, Fazal Mabood, Asaad Khalid, Kwang-Hyun Baek, Ahmed Al-Harrasi , Journal (2024)